According to a new study, heart patients who take aspirin and also treat their arthritis with ibuprofen are nine times more likely to suffer a heart attack. People taking both of these medications should be very careful when combining the two.
According to the Food and Drug Administration (FDA), a bladder drug used to treat overactive bladder conditions needs more specific warnings for children. Oxybutynin, sold under the brand name Diptropan, has the potential to cause hallucinations and agitation in children.
Public Citizen, a consumer advocacy group, has gone to the Food and Drug Administration (FDA) to stop Pfizer from airing their new Celebrex television ad. The ad began last week after the FDA put a stop to them in 2004 over concerns the drug raised the risks of heart attacks and strokes.
A new report has concluded that the risk of heart disease and stroke increases with age for women using postmenopausal hormone therapy. Use of estrogen and estrogen-plus-progestin treatments presented the most life-threatening results for women in their 60s and 70s, while women in their 50s did not see significant adverse affects.